SYNOPSYS INC
For the period ended Apr 10, 2024. Filed Feb 16, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 10, 2024 · Filed Feb 16, 2024
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
| Filed by the Registrant ☒ | |
|---|---|
| Filed by a Party other than the Registrant ☐ | |
| Check the appropriate box: | |
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
Synopsys, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of Filing Fee (Check all boxes that apply): | |
|---|---|
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
LETTER TO OUR STOCKHOLDERS
Dear Synopsys Stockholder,
Synopsys delivered another outstanding year in fiscal 2023 despite global macroeconomic uncertainty. We have a resilient business model, and our customers continue to rely on Synopsys’ design solutions as they prioritize investments in the silicon and systems that position them for future success. We are aligning our portfolio investment with our core EDA and IP businesses, which hold the greatest return potential to accelerate our Silicon to Systems strategy and growth. We are confident in our business heading into fiscal 2024 based on our technology leadership, strong customer momentum and the resiliency of our time-based business model.Business & Financial ResultsWe delivered a record year in fiscal 2023 including:•Record revenue of $5.8 billion, up approximately 15% year-over-year;•Improved GAAP operating margin to 21.7% and non-GAAP operating margin to 35.1%;•Approximately 26% GAAP and non-GAAP earnings per share growth;•Approximately $1.7 billion of operating cash flow; •Returned approximately $1.2 billion to stockholders through stock repurchases; and•Expanded our backlog to $8.6 billion.Product Innovation Core to our business success are the many high impact innovations across our portfolio that we've introduced over the past several years. The drumbeat of customer adoption and proliferation of these solutions continues, bolstered by important new products and partnerships introduced in fiscal 2023, including:•Pioneering AI-driven chip design with the launch of Synopsys.ai™, the industry's first full-stack EDA suite delivering production-proven, AI-driven optimization, data analytics, and generative AI capabilities to chipmakers across all stages of IC chip development;•Delivering the industry’s broadest, most comprehensive IP portfolio on advanced process nodes across the world’s leading foundries, including a wide range of high-performance, automotive-grade IP in 5nm; and•Advancing the development and adoption of multi-die systems with comprehensive and silicon-proven EDA & IP solutions for fast, heterogeneous integration.
Our Technology
We focus ourtechnology aroundthree essential pillars.Silicon Design &VerificationBuild high-performance,low power silicon chips, fasterSilicon IPIntegrate morecapabilities on SoCs(System on Chip),fasterSoftware Security & QualityBuild more secure, higher quality software, faster
Our differentiated portfolio, ranging from the critical base of silicon design and verification all the way up to the system design, are key engineering catalysts of the ‘Era of Pervasive Intelligence,’ where AI and smart technologies are omnipresent and interconnected. To capitalize on this era, the technology industry is innovating with new paradigms in silicon-to-systems design. As the company at the heart of silicon and systems, we believe Synopsys is uniquely positioned to address the challenges technology R&D teams face when building highly complex systems, whether an advanced AI processor, a cutting-edge datacenter or a software-defined vehicle.
Corporate Governance
At Synopsys, we aspire and are committed to constantly learn and evolve towards being a great and enduring company. A critical foundation is having both an outstanding executive management team and a strong Board of Directors to enable the success of our customers and further the long-term interests of our stockholders. To that end, we effected several important leadership transitions to our executive management team. For example, following a systematic, multi-year succession planning process, Sassine Ghazi succeeded Dr. Aart de Geus as Chief Executive Officer of Synopsys while continuing in his role as President. In addition, Aart transitioned to the role of Executive Chair of our Board. We also enhanced our Board with the addition of two new directors, and we believe we have an outstanding Board with directors that stand out through their combination of strengths, skills, knowledge, experience and diversity.
| 2024 Proxy Statement | 1 |
|---|
Letter to Our Stockholders
| While our CEO has changed, our culture will not. Synopsys will continue to operate with integrity, execution excellence, leadership and passion, and we continue to be a company that cares deeply about its people, the environment and the communities in which we operate. In conclusion, Synopsys remains focused on relentlessly advancing our mission of empowering technology innovators everywhere with Silicon to Systems design solutions that solve our customers’ toughest challenges and ignite future innovation!The entire team at Synopsys thanks you for your support and your belief in the power and potential of our company. Our future is bright, and we are enthusiastically embracing our high ambitions and the exciting journey ahead. | |
|---|---|
| Dr. Aart J. de Geus Executive Chair of the Board of Directors | Sassine Ghazi President and Chief Executive Officer |
2
NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS
| Date and TimeApril 10, 2024 (Wednesday)8:00 AM (Pacific Time) | LocationOnline at www.virtualshareholder meeting.com/SNPS2024 | Who Can VoteStockholders as of February 12, 2024 are entitled to vote. |
Dear Stockholder,
You are cordially invited to attend the 2024 Annual Meeting of Stockholders of Synopsys, Inc. (Synopsys), a Delaware corporation, which will be held virtually via live webcast on April 10, 2024, at 8:00 a.m. Pacific Time (the Annual Meeting). You will be able to attend and participate in the Annual Meeting online, vote your shares electronically, and submit your questions during the meeting by visitingwww.virtualshareholdermeeting.com/SNPS2024.
We are holding the meeting for the following purposes, which are more fully described in the attached Proxy Statement.
VOTING ITEMS
| Proposals | Board VoteRecommendation | For FurtherDetails | |
| 1. | To elect eleven directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected | “FOR” each director nominee | Page 11 |
| 2. | To approve our 2006 Employee Equity Incentive Plan, as amended | “FOR” | Page 38 |
| 3. | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement | “FOR” | Page 49 |
| 4. | To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending November 2, 2024 | “FOR” | Page 96 |
| 5. | To vote on a stockholder proposal regarding an independent Board chair requirement, if properly presented at the meeting | “AGAINST” | Page 99 |
We will also consider any other business that properly comes before the Annual Meeting or any adjournment or postponement thereof. As of the close of business on February 12, 2024, we are not aware of any other matters to be submitted for consideration at the Annual Meeting.
All of our stockholders of record at the close of business on February 12, 2024 are entitled to attend and vote at the Annual Meeting. A list of registered stockholders entitled to vote at the meeting will be available for ten days until the end of the day before the meeting. If you want to inspect this list, email our Investor Relations department at synopsys-ir@synopsys.com.
Whether or not you plan to attend the Annual Meeting, we urge you to cast your vote in advance of the Annual Meeting via one of the methods described below and in the attached Proxy Statement. The Proxy Statement contains important information for you to consider when deciding how to vote on the above items. You do not need to attend the Annual Meeting in order to vote. For most items being put to a vote, if you do not provide voting instructions in person (virtually), via the Internet, by telephone, or by returning the proxy card or voting instruction card, your shares will not be voted. Please vote as promptly as possible. Every stockholder vote is important. Please see the section titled “About the Annual Meeting” beginning on page 104 for answers to common questions about the Annual Meeting, voting, attendance, submitting a proposal for next year’s annual meeting of stockholders, and other procedures.
Sincerely yours,
John F. Runkel, Jr.
General Counsel and Corporate Secretary
Sunnyvale, California
February 16, 2024
HOW TO VOTE
| Internet | Telephone | |
|---|---|---|
| www.proxyvote.com | 1-800-690-6903 | Mark, sign, date and promptly mail the enclosedproxy card in the postage-paid envelope |
Important Notice Regarding the Internet Availability of Proxy Materials for the Annual Meeting to Be Held on April 10, 2024
The Proxy Statement and our Annual Report on Form 10-K for the year ended October 28, 2023 will be available to stockholders athttp://www.proxyvote.comon or
about February 16, 2024.
| 2024 Proxy Statement | 3 |
|---|
TABLE OF CONTENTS
| Letter to Our Stockholders | 1 |
|---|---|
| Notice of 2024 Annual Meeting of Stockholders | 3 |
| Proxy Statement Summary | 5 |
| Corporate Governance | 11 |
| PROPOSAL 1 — Election of Directors | 11 |
| Board of Directors | 12 |
| Board of Directors Role and Responsibilities | 23 |
| Board of Directors Leadership Structure | 30 |
| Board of Directors Practices, Policies and Processes | 33 |
| Director Compensation | 35 |
| PROPOSAL 2 — Approval of Our 2006 Employee Equity Incentive Plan, as Amended | 38 |
| Purpose and Background | 38 |
| Important Features of the 2006 Employee Plan | 39 |
| Description of the 2006 Employee Plan | 40 |
| New Plan Benefits and Historical Grant Information | 47 |
| PROPOSAL 3 — Advisory Vote to Approve Executive Compensation | 49 |
| Compensation Discussion and Analysis | 49 |
| Compensation Committee Report | 77 |
| Compensation Risk Assessment | 78 |
| Compensation Committee Interlocks and Insider Participation | 78 |
| Executive Compensation Tables | 79 |
| Pay Ratio Disclosure | 90 |
| Pay Versus Performance Disclosure | 91 |
| Equity Compensation Plan Information | 95 |
| Audit Matters | 96 |
| PROPOSAL 4 — Ratification of Selection of Independent Registered Public Accounting Firm | 96 |
| Fees and Service of Independent Registered Public Accounting Firm | 96 |
| Audit Committee Pre-Approval Policies and Procedures | 97 |
| Audit Committee Report | 97 |
| Stockholder Proposal | 99 |
| PROPOSAL 5 — Independent Board Chair | 99 |
| Security Ownership of Certain Beneficial Owners and Management | 102 |
| Additional Information | 104 |
| About the Annual Meeting | 104 |
| Stockholder Information | 108 |
| Forward-Looking Statements | 109 |
| Information Referenced in this Proxy Statement | 109 |
| Other Matters | 109 |
| Appendices | 110 |
| Appendix A | 110 |
| Appendix B | 127 |
4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.